Boots Cough Syrup 3 Months Plus Interactions
There are 242 drugs known to interact with Boots Cough Syrup 3 Months Plus (glycerin), along with 2 disease interactions. Of the total drug interactions, 241 are moderate, and 1 is minor.
Medications known to interact with Boots Cough Syrup 3 Months Plus
Note: Showing generic names only.
- abarelix
- abiraterone
- acetazolamide
- adagrasib
- albuterol
- alfuzosin
- amiloride
- amiodarone
- amisulpride
- anagrelide
- apalutamide
- apomorphine
- arsenic trioxide
- asciminib
- asenapine
- astemizole
- atomoxetine
- azithromycin
- bedaquiline
- benazepril
- bendroflumethiazide
- benzthiazide
- bepridil
- betamethasone
- bicalutamide
- bosutinib
- bumetanide
- buprenorphine
- cabozantinib
- captopril
- carbamazepine
- ceritinib
- chlorothiazide
- chlorpromazine
- chlorthalidone
- cilostazol
- ciprofloxacin
- cisapride
- citalopram
- clarithromycin
- clofazimine
- clozapine
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- crizotinib
- dasatinib
- deflazacort
- degarelix
- demeclocycline
- deutetrabenazine
- dexamethasone
- dichlorphenamide
- digitoxin
- digoxin
- disopyramide
- dofetilide
- dolasetron
- doxycycline
- dronedarone
- droperidol
- efavirenz
- enalapril
- enalaprilat
- encorafenib
- entrectinib
- enzalutamide
- epoprostenol
- eravacycline
- eribulin
- erythromycin
- escitalopram
- ethacrynic acid
- etrasimod
- ezogabine
- flecainide
- fluconazole
- fludeoxyglucose f18
- fludrocortisone
- fluoxetine
- fluphenazine
- flutamide
- foscarnet
- fosinopril
- fostemsavir
- furosemide
- gatifloxacin
- gemifloxacin
- gepirone
- gilteritinib
- givinostat
- glasdegib
- goserelin
- granisetron
- grepafloxacin
- halofantrine
- haloperidol
- histrelin
- hydrochlorothiazide
- hydrocortisone
- hydroflumethiazide
- hydroxychloroquine
- hydroxyzine
- ibutilide
- iloperidone
- iloprost
- indapamide
- inotuzumab ozogamicin
- irinotecan
- irinotecan liposomal
- ivosidenib
- lactulose
- lapatinib
- lefamulin
- lenvatinib
- leuprolide
- levofloxacin
- levoketoconazole
- levomethadyl acetate
- linaclotide
- lisdexamfetamine
- lisinopril
- lofexidine
- lomefloxacin
- mannitol
- mavorixafor
- mefloquine
- mesoridazine
- methadone
- methazolamide
- methotrimeprazine
- methyclothiazide
- methylprednisolone
- metolazone
- midostaurin
- mifepristone
- minocycline
- mirtazapine
- mobocertinib
- moexipril
- moxifloxacin
- ofloxacin
- oliceridine
- omadacycline
- ondansetron
- osilodrostat
- osimertinib
- oxaliplatin
- oxytetracycline
- oxytocin
- ozanimod
- pacritinib
- paliperidone
- palonosetron
- panobinostat
- pasireotide
- pazopanib
- pentamidine
- perflutren
- perindopril
- perphenazine
- pimavanserin
- pimozide
- pitolisant
- polythiazide
- ponesimod
- posaconazole
- pralsetinib
- prednisolone
- prednisone
- primaquine
- probucol
- procainamide
- prochlorperazine
- promazine
- propafenone
- propofol
- propoxyphene
- saquinavir
- selexipag
- selpercatinib
- sertraline
- sevoflurane
- siponimod
- solifenacin
- sorafenib
- sotalol
- sparfloxacin
- spironolactone
- sunitinib
- tebentafusp
- telavancin
- telithromycin
- terbutaline
- terfenadine
- tetrabenazine
- tetracycline
- thioridazine
- tigecycline
- toremifene
- torsemide
- tramadol
- trandolapril
- trazodone
- treprostinil
- triamcinolone
- triamcinolone ophthalmic
- triamterene
- trichlormethiazide
- triclabendazole
- trifluoperazine
- triflupromazine
- trimeprazine
- triptorelin
Boots Cough Syrup 3 Months Plus disease interactions
There are 2 disease interactions with Boots Cough Syrup 3 Months Plus (glycerin) which include:
More about Boots Cough Syrup 3 Months Plus (glycerin)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.